The largest database of trusted experimental protocols

Human recombinant or bovine insulin

Manufactured by Merck Group

Human recombinant or bovine insulin is a laboratory product used for research and development purposes. It serves as a core component in the study and analysis of insulin-related biochemical processes. The product provides a standardized source of insulin for scientific investigations, without interpretation or extrapolation on its intended use.

Automatically generated - may contain errors

2 protocols using human recombinant or bovine insulin

1

Cardiac Progenitor Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
At day 6, cardiac progenitor cells were singularized with Accutase at 37°C for 5 min and then seeded onto a gelatin- or SyntheMax-coated cell culture plate at 20,000–80,000 cells/cm2 (or 1:3–1:12 split) in LaSR basal medium (advanced DMEM/F12 with 100 μg/mL ascorbic acid) or RPMI/Vc/Ins medium (100 μg/mL ascorbic acid and 1 μg/mL human recombinant or bovine insulin (Sigma)) with 5 μM ROCK inhibitor Y-27632 for 24 hours. The addition of 1% human recombinant albumin (Sigma) or fetal bovine serum (FBS) can improve cell attachment and survival, but they are not required. At day 7, cells were treated with 1–9 μM CHIR99021 for 2 days in LaSR basal medium or RPMI/insulin/Vc medium. CHIR99021-containing medium was aspirated on day 9 and cells were cultured in LaSR basal medium or RPMI/insulin/Vc medium without CHIR99021 for 3–5 additional days, as explained previously14 (link).
+ Open protocol
+ Expand
2

Cardiac Progenitor Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
At day 6, cardiac progenitor cells were singularized with Accutase at 37°C for 5 min and then seeded onto a gelatin- or SyntheMax-coated cell culture plate at 20,000–80,000 cells/cm2 (or 1:3–1:12 split) in LaSR basal medium (advanced DMEM/F12 with 100 μg/mL ascorbic acid) or RPMI/Vc/Ins medium (100 μg/mL ascorbic acid and 1 μg/mL human recombinant or bovine insulin (Sigma)) with 5 μM ROCK inhibitor Y-27632 for 24 hours. The addition of 1% human recombinant albumin (Sigma) or fetal bovine serum (FBS) can improve cell attachment and survival, but they are not required. At day 7, cells were treated with 1–9 μM CHIR99021 for 2 days in LaSR basal medium or RPMI/insulin/Vc medium. CHIR99021-containing medium was aspirated on day 9 and cells were cultured in LaSR basal medium or RPMI/insulin/Vc medium without CHIR99021 for 3–5 additional days, as explained previously14 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!